Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial-Reference-Cited by-同舟云学术

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Published:2023-05-11 Issue:6 Volume:12 Page:1605-1624
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Choi Yu Hwa,Kang Young Ae,Park Kwang Joo,Choi Jae Chol,Cho Kwan Goo,Ko Da Yeon,Ahn Jun Ho,Lee Boram,Ahn Eunsol,Woo Yun Ju,Jung Kwangsoo,Kim Nan Yul,Reese Valerie A.,Larsen Sasha E.,Baldwin Susan L.,Reed Steven G.,Coler Rhea N.,Lee Hyejon^ORCID,Cho Sang-Nae

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-023-00806-0.pdf

Reference30 articles.

1. World Health Organization. Tuberculosis (TB): fact sheets. 2022. https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed 30 Nov 2022.

2. Cohen A, Mathiasen VD, Schön T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54:1900655. https://doi.org/10.1183/13993003.00655-2019.

3. Korea Disease Control and Prevention Agency. Annual report on the notified tuberculosis patients in Korea 2019. 2020. http://www.kdca.go.kr/npt/biz/npp/portal/nppPblctDtaView.do?pblctDtaSeAt=1&pblctDtaSn=2088. Accessed 30 Nov 2022.

4. Clemens JD, Chuong JJ, Feinstein AR. The BCG controversy. A methodological and statistical reappraisal. JAMA. 1983;249:2362–9. https://doi.org/10.1001/jama.1983.03330410048027.

5. Menzies R, Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992;145:621–5. https://doi.org/10.1164/ajrccm/145.3.621.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From pathogenesis to antigens: the key to shaping the future of TB vaccines;Frontiers in Immunology;2024-07-23

2. BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice;npj Vaccines;2024-03-08